AbbVie (NYSE: ABBV), a global pharmaceutical leader, and the PGA TOUR today announced a partnership naming AbbVie the Official Pharmaceutical Sponsor of the PGA TOUR and the 2026 Presidents Cup.
Zacks Investment Research on MSN
How AbbVie's neuroscience portfolio has transformed over the years
AbbVie ABBV has significantly transformed its neuroscience portfolio over the years, evolving it from a relatively ...
AbbVie launches Birdies for Brain Health with the PGA TOUR, raising funds for people affected by neurological and mental ...
The agreement makes AbbVie, which reported $3.2 billion in neuroscience sales in the second quarter, the official pharmaceutical sponsor of the PGA Tour, a professional golf organization. This month’s ...
The MarketWatch News Department was not involved in the creation of this content. Nonprofits are invited to submit innovative solutions that increase access to care in communities across the U.S. and ...
Key Points Interested in AbbVie Inc.? Here are five stocks we like better. SKYRIZI and RINVOQ remain AbbVie’s main growth ...
AbbVie Inc. (NYSE:ABBV) on Monday shared topline results from the Phase 2 ELATE trial evaluating onabotulinumtoxinA (BOTOX) compared to placebo for upper limb essential tremor. Upper limb essential ...
NORTH CHICAGO, Ill., Feb. 24, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026. Management will participate in a ...
None of the Big Pharma players has succeeded in challenging AbbVie's dominance in the immune-mediated inflammatory diseases market. In my view, this is directly related to the near-perfect ...
AbbVie focuses on specialized therapies in immunology, oncology, and neuroscience. The company sells these treatments globally, relying heavily on three major wholesale distributors: McKesson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results